This story has been updated to correct Marjanka Schmidt's academic affiliation.
NEW YORK – A polygenic risk score for breast cancer can not only identify individuals at increased risk of developing primary breast cancer but also those carrying a higher risk of developing contralateral breast cancer, according to a new study.